Yuan Z, Jiang H, Xu C
Department of pathology, Xinxiang Medical College, Henan.
Zhonghua Bing Li Xue Za Zhi. 1996 Jun;25(3):159-61.
In order to investigate the intratumoral DNA ploid heterogeneity in esophageal squamous cell carcinoma and its significance, nuclear DNA ploidy of 80 cases of squamous cell carcinoma of the esophagus were determined for multiple samples obtained from the same tumor, using a flow cytometry (FCM) technique. The results showed that: (1) DNA indeces ranged from 7.7-1.74, and the incidence of DNA aneuploidy was 88.8% (71/80) in this series; (2) of 80 cases, (47.5% 38 cases) showed intratumoral heterogeneity in DNA ploidy (3) the heterogeneity in DNA ploidy was related to the extent of wall penetration by tumor, the incidnce of lymph node metastasis and patient's prognosis, not to histological grades and size of tumor. The results from this study indicated that DNA ploidy heterogeneity may be a exact indicator in reflecting the biological characteristics of tumor and patient's prognosis than DNA aneuploidy from single site sampling.
为探讨食管鳞状细胞癌瘤内DNA倍体异质性及其意义,应用流式细胞术(FCM)对80例食管鳞状细胞癌同一肿瘤的多个样本进行核DNA倍体测定。结果显示:(1)本研究中DNA指数范围为7.7 - 1.74,DNA非整倍体发生率为88.8%(71/80);(2)80例中,47.5%(38例)显示肿瘤内DNA倍体存在异质性;(3)DNA倍体异质性与肿瘤侵犯管壁深度、淋巴结转移发生率及患者预后相关,而与肿瘤的组织学分级及大小无关。本研究结果表明,与单点采样的DNA非整倍体相比,DNA倍体异质性可能是反映肿瘤生物学特性及患者预后更准确的指标。